1,200
Participants
Start Date
May 20, 2020
Primary Completion Date
May 17, 2021
Study Completion Date
May 17, 2021
Heparin
"Low molecular weight heparin (LMWH) Preferred therapeutic anticoagulant is enoxaparin. Generally regimens: 1.5 mg/kg subcutaneous once daily or 1 mg/kg subcutaneous twice daily. Alternatively, other subcutaneous LMWH used, including tinzaparin (175 anti-Xa IU/kg subcutaneous once daily) or dalteparin (200 IU/kg subcutaneous once daily or 100 IU/kg subcutaneous twice a day).~Unfractionated heparin (UFH) Commenced, administered, and monitored according to local hospital policy, and guidelines that are used for the treatment of venous thromboembolism (i.e. not for acute coronary syndrome). Intravenous infusion of UFH is according to total body weight and pragmatically adjusted according to local institutional policy to achieve an activated partial thromboplastin time (aPTT) of 1.5-2.5x the reference value. If UFH is used, the availability of a local hospital policy that has specifies an aPTT target in this range or an anti-Xa value is a requirement."
Montefiore-Einstein Center for Heart and Vascular Care, New York
Emory University Hospital Midtown, Atlanta
Vanderbilt University Medical Center, Nashville
Henry Ford University, Dearborn
Beaumont Hospital, Royal Oak
Mayo Clinic, Rochester
University of Chicago, Chicago
Saint Louis University School of Medicine/Saint Louis Veterans Affairs Medical Center, St Louis
Ochsner Clinic, Jefferson
Maine Medical Center, Portland
Cooper University Health Care, Camden
Hackensack University Medical Center, Hackensack
Saint Barnabas Medical Center, Livingston
Hospital Unimed do Cariri, Juazeiro do Norte
Santa Casa de Misericordia de Itabuna, Itabuna
Instituto Goiano de Oncologia e Hematologia - INGOH, Goiânia
Centro de Pesquisas Clínicas Humap - UFMS, Campo Grande
Clinica de Campo Grande S/A, Campo Grande
Unimed Campo Grande, Campo Grande
Hospital Felício Rocho, Belo Horizonte
Hospital das Clinicas da UFPR, Curitiba
Pontifícia Universidade Católica do Paraná, Curitiba
Parana Medical Research Center, Maringá
Hospital Agamenon Magalhaes, Recife
Hospital Universitario Pedro Ernesto, Rio de Janeiro
Hospital Sao Vicente de Paulo, Passo Fundo
Hospital de Clinicas de Porto Alegre, Porto Alegre
Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre
Instituto de Medicina Vascular, Porto Alegre
AngioCor Blumenau, Blumenau
Instituto de Cardiologia de Santa Catarina, São José
Instituto de Pesquisa Clínica de Campinas, Campinas
Praxis Pesquisa Medica, Santo André
Casa de Saúde Santa Marcelina, São Paulo
Instituto de Molestias Cardio Vasculares de Tatui, Tatuí
Santa Casa de Votuporanga, Votuporanga
Hospital 9 de Julho, São Paulo
Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo
Instituto de Infectologia Emilio Ribas, São Paulo
Instituto do Coração do Estado de São Paulo, São Paulo
Sociedade Beneficente Israelita Hospital Albert Einstein, São Paulo
Victoria General Hospital, Victoria
Grace General Hospital, Winnipeg
St. Boniface General Hospital, Winnipeg
Hamilton Health Sciences, Hamilton
St. Joseph's Healthcare Hamilton, Hamilton
Hôpital Montfort, Ottawa
The Ottawa Hospital, Ottawa
Centre Hospitalier de l'université de Montréal (CHUM), Montreal
Jewish General Hospital, Montreal
CHU de Quebec-University Laval, Québec
Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Québec
Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke
Regina General Hospital, Regina
Hospital de Infectolog´ñia Centro Médico Nacional La Raza, Azcapotzalco
Hospital General Regional 1 Carlos MacGregor Sánchez Navarro, Benito Juárez
Hospital General regional 2 El Marqués, Querétaro
Health Sciences Center Winnipeg, Winnipeg
University Health Network, Toronto
McGill University Health Centre, Montreal
University Health Network, Toronto
OTHER
University of Manitoba
OTHER